Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery

Devasier Bennet,1 Mohana Marimuthu,1 Sanghyo Kim,1 Jeongho An21Department of Bionanotechnology, Gachon University, Gyeonggi, Republic of Korea; 2Department of Polymer Science and Engineering, SunKyunKwan University, Gyeonggi, Republic of KoreaAbstract: Antioxidant (quercetin) and hypoglycemic (vogli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bennet D, Marimuthu M, Kim S, An J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/0cb0178dd36c43fcbd3a52fb0c26a3e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0cb0178dd36c43fcbd3a52fb0c26a3e6
record_format dspace
spelling oai:doaj.org-article:0cb0178dd36c43fcbd3a52fb0c26a3e62021-12-02T00:40:16ZDual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery1176-91141178-2013https://doaj.org/article/0cb0178dd36c43fcbd3a52fb0c26a3e62012-07-01T00:00:00Zhttp://www.dovepress.com/dual-drug-loaded-nanoparticles-on-self-integrated-scaffold-for-control-a10415https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Devasier Bennet,1 Mohana Marimuthu,1 Sanghyo Kim,1 Jeongho An21Department of Bionanotechnology, Gachon University, Gyeonggi, Republic of Korea; 2Department of Polymer Science and Engineering, SunKyunKwan University, Gyeonggi, Republic of KoreaAbstract: Antioxidant (quercetin) and hypoglycemic (voglibose) drug-loaded poly-D,L-lactide-co-glycolide nanoparticles were successfully synthesized using the solvent evaporation method. The dual drug-loaded nanoparticles were incorporated into a scaffold film using a solvent casting method, creating a controlled transdermal drug-delivery system. Key features of the film formulation were achieved utilizing several ratios of excipients, including polyvinyl alcohol, polyethylene glycol, hyaluronic acid, xylitol, and alginate. The scaffold film showed superior encapsulation capability and swelling properties, with various potential applications, eg, the treatment of diabetes-associated complications. Structural and light scattering characterization confirmed a spherical shape and a mean particle size distribution of 41.3 nm for nanoparticles in the scaffold film. Spectroscopy revealed a stable polymer structure before and after encapsulation. The thermoresponsive swelling properties of the film were evaluated according to temperature and pH. Scaffold films incorporating dual drug-loaded nanoparticles showed remarkably high thermoresponsivity, cell compatibility, and ex vivo drug-release behavior. In addition, the hybrid film formulation showed enhanced cell adhesion and proliferation. These dual drug-loaded nanoparticles incorporated into a scaffold film may be promising for development into a transdermal drug-delivery system.Keywords: quercetin, voglibose, biocompatible materials, encapsulation, transdermalBennet DMarimuthu MKim SAn JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 3399-3419 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Bennet D
Marimuthu M
Kim S
An J
Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
description Devasier Bennet,1 Mohana Marimuthu,1 Sanghyo Kim,1 Jeongho An21Department of Bionanotechnology, Gachon University, Gyeonggi, Republic of Korea; 2Department of Polymer Science and Engineering, SunKyunKwan University, Gyeonggi, Republic of KoreaAbstract: Antioxidant (quercetin) and hypoglycemic (voglibose) drug-loaded poly-D,L-lactide-co-glycolide nanoparticles were successfully synthesized using the solvent evaporation method. The dual drug-loaded nanoparticles were incorporated into a scaffold film using a solvent casting method, creating a controlled transdermal drug-delivery system. Key features of the film formulation were achieved utilizing several ratios of excipients, including polyvinyl alcohol, polyethylene glycol, hyaluronic acid, xylitol, and alginate. The scaffold film showed superior encapsulation capability and swelling properties, with various potential applications, eg, the treatment of diabetes-associated complications. Structural and light scattering characterization confirmed a spherical shape and a mean particle size distribution of 41.3 nm for nanoparticles in the scaffold film. Spectroscopy revealed a stable polymer structure before and after encapsulation. The thermoresponsive swelling properties of the film were evaluated according to temperature and pH. Scaffold films incorporating dual drug-loaded nanoparticles showed remarkably high thermoresponsivity, cell compatibility, and ex vivo drug-release behavior. In addition, the hybrid film formulation showed enhanced cell adhesion and proliferation. These dual drug-loaded nanoparticles incorporated into a scaffold film may be promising for development into a transdermal drug-delivery system.Keywords: quercetin, voglibose, biocompatible materials, encapsulation, transdermal
format article
author Bennet D
Marimuthu M
Kim S
An J
author_facet Bennet D
Marimuthu M
Kim S
An J
author_sort Bennet D
title Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
title_short Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
title_full Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
title_fullStr Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
title_full_unstemmed Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
title_sort dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/0cb0178dd36c43fcbd3a52fb0c26a3e6
work_keys_str_mv AT bennetd dualdrugloadednanoparticlesonselfintegratedscaffoldforcontrolleddelivery
AT marimuthum dualdrugloadednanoparticlesonselfintegratedscaffoldforcontrolleddelivery
AT kims dualdrugloadednanoparticlesonselfintegratedscaffoldforcontrolleddelivery
AT anj dualdrugloadednanoparticlesonselfintegratedscaffoldforcontrolleddelivery
_version_ 1718403537994514432